Funding for climate tech has contracted in recent years. What makes Gothenburg so unique in its ability to fund, scale and ...

IonQ's strong revenue growth and partnerships with industry leaders are promising, but high operating expenses and reliance ...

Maria joined AstraZeneca in 2017 as head of Respiratory ... in Cardiovascular Physiology/Pharmacology from the University of Gothenburg, Sweden. What inspired you to work in the life sciences ...

near Gothenburg. This now looks odds-on to be shut down if Pfizer secures the takeover bid in the next few weeks. Many US commentators are predicting closure of Pfizer and AstraZeneca research ...

Marquis Who's Who honors Jan M. Lundberg, PhD, for his expertise in pharmaceuticals and research. Dr. Lundberg has over 30 years of professional experience in the pharmaceutical industry.

He holds a position as an Associate Principal Scientist of Chemical/Formulation Characterization With Vibrational Spectroscopy at AstraZeneca, Gothenburg, Sweden. His current focus is on process ...

The research teams constitute a world-leading research environment and make a strong contribution to the University of Gothenburg’s top ranking ... a joint doctoral student together with AstraZeneca.

Gothenburg Center for Sustainability Development (GMV) Private organizations and businesses, for instance RISE and AstraZeneca Public organisations such as IVL Swedish environmental research institute ...

AstraZeneca (NASDAQ:AZN) is one of the biggest players in the healthcare sector, whose medicines save the lives of tens of thousands of people every year. In this article, I will share six reasons ...

Jan 17 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca (AZN.L), opens new tab and partner Daiichi Sankyo's (4568.T), opens new tab precision drug to treat a type of ...